Publication | Open Access

Decline of mumps antibodies in Type 1 (insulin-dependent) diabetic children and a plateau in the rising incidence of Type 1 diabetes after introduction of the mumps-measles-rubella vaccine in Finland

VaccinationType 1Vaccine DevelopmentMumps-measles-rubella VaccineImmunodeficienciesDiabetesImmunologyVaccine TargetMumps AntibodiesMedicineVaccine Research